Missionbio.com Website Review

Mission Bio’s Tapestri® Platform provides unprecedented insight into the heterogeneity among cells that drive complex diseases like cancer, so you can map disease progression and better guide dynamic treatment. Mission Bio Raises $30M to accelerate Single-Cell DNA An*lysis! No technology prior to Tapestri has been able to give us the resolution to decipher co-occurring mutations in the same clones. These insights are especially important in our study of resistance mechanisms and combinatorial therapies in key clinical trials. “To accelerate the understanding of response, resistance, and relapse, it is important to move away from bulk sequencing and make This new capability of single-cell an*lysis is critical to better understanding precision therapy selection at diagnosis as well as We use cutting edge single-cell techniques like the Tapestri Platform to give us insights into the selective advantages certain mutations confer in hematopoietic stem and progenitor cells, along with examining clonal heterogeneity including in the detection of minimal We have a profound gap in knowledge between the interaction of a person, their cancer, and their therapy and how that impacts response. The promise of precision medicine is to deliver highly targeted treatment to every single diseased cell. The current one-size-fits-all approach of medical treatments isn’t working for many patients who need help. To move precision medicine forward, researchers and clinicians need to look at the origins of disease — the single cell — in meaningful new ways. The Tapestri Platform delivers targeted solutions for high-impact application areas, including blood cancers, solid tumors, and genome Tapestri is the industry’s first targeted single-cell DNA sequencing platform, enabling precise detection of heterogeneity in disease progression and treatment response. The platform includes an instrument, consumables, and an*lysis software, which integrate seamlessly with existing NGS workflows. With Tapestri, researchers have a highly sensitive, targeted, and customizable solution to move